MANTIS PHOTONICS
Alzheimer’s Disease
Over 30 million people are
affected worldwide
300 billion dollars are spent yearly
on the treatment of the affected
3 times more people expected
to be affected in 2050
Primary care: 50 – 70 % of patients are not diagnosed or get the wrong diagnosis
Specialist care: 20 – 30 % of patients get the wrong diagnosis
Lumbar punction and PET scan:
accessibility limited due to
cost Neuropsychologist is inaccessible
Lumbar punction is perceived as invasive
Cognitive screening instruments are insensitive
Our Solution: Early Detection
Alzheimer disease is often recognized by patients from its early symptoms such as memory loss, difficulty completing familiar tasks, confusion with time or place. However the first physiological changes in the brain happens a decade before. With our technology, we want to redefine the patient journey by screening the population. Such screening will enable the patients to take preventive measure that can delay or avoid the onset of Alzheimer. What is more early screening allows the patient to be closely monitored and thus treated in time making the treatment more effective.